Form 8-K - Current report:
SEC Accession No. 0001641172-25-016394
Filing Date
2025-06-25
Accepted
2025-06-25 09:22:58
Documents
17
Period of Report
2025-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 47810
2 EX-10.1 ex10-1.htm EX-10.1 254335
3 EX-10.2 ex10-2.htm EX-10.2 79460
4 EX-10.3 ex10-3.htm EX-10.3 118355
5 EX-99.1 ex99-1.htm EX-99.1 13723
6 EX-99.2 ex99-2.htm EX-99.2 13101
  Complete submission text file 0001641172-25-016394.txt   800492

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE shph-20250620.xsd EX-101.SCH 3029
8 XBRL LABEL FILE shph-20250620_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE shph-20250620_pre.xml EX-101.PRE 22368
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 251071278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)